Systematic review of the effect of denosumab on children with osteogenesis imperfecta showed inconsistent findings
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- March 2018
has subject area
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Bone Density (MeSH)
- Bone Density Conservation Agents (MeSH)
- Child (MeSH)
- Child, Preschool (MeSH)
- Denosumab (MeSH)
- Dose-Response Relationship, Drug (MeSH)
- Drug Administration Schedule (MeSH)
- Evidence-Based Medicine (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Injections, Subcutaneous (MeSH)
- Male (MeSH)
- Osteogenesis Imperfecta (MeSH)
- Pediatrics (Science Metrix)
- Prognosis (MeSH)
- Severity of Illness Index (MeSH)
- Treatment Outcome (MeSH)